Journal of Radioanalytical and Nuclear Chemistry

, Volume 302, Issue 3, pp 1253–1258 | Cite as

Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC

  • Archana Mukherjee
  • Usha Pandey
  • Rubel Chakravarty
  • Haladhar Dev Sarma
  • Ashutosh Dash


This paper describes the development of a lyophilized cold kit of DOTA-[Tyr3]-Octreotide (DOTA-TOC) for instant compounding of 68Ga-DOTA-TOC, suitable for diagnosis of neuroendocrine tumors. The work involved formulation of DOTA-TOC kits, optimization of radiolabeling, quality control of 68Ga-DOTA-TOC and animal biodistribution studies. The prepared kits enable a reliable method for preparation of 68Ga-DOTA-TOC of high radiochemical purity and excellent stability. Availability of such kits along with 68Ge/68Ga generators is expected to stimulate the widespread use of 68Ga-DOTA-TOC in nuclear medicine practice in developing countries.


68Ge/68Ga generator 68Ga-DOTA-[Tyr3]-octreotide Lyophilized cold kit PET imaging 



Research at the Bhabha Atomic Research Centre (BARC) is part of the ongoing activities of the Department of Atomic Energy, India, and is fully supported by government funding. The authors express their sincere thanks to Dr. M.R.A. Pillai, former Head, Radiopharmaceuticals Division, BARC for initiating this work. The authors are thankful to Dr. K.L. Ramakumar, Director (I), RC& I Group, BARC for encouragement and support.


  1. 1.
    Velikyan I (2013) Theranostics 4:47CrossRefGoogle Scholar
  2. 2.
    Banerjee SR, Pomper MG (2013) Appl Radiat Isot 76:2CrossRefGoogle Scholar
  3. 3.
    Decristoforo C, Pickett RD, Verbruggen A (2012) Eur J Nucl Med Mol Imaging 39:S31CrossRefGoogle Scholar
  4. 4.
    Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ, Krenning EP (2011) Semin Nucl Med 41:314CrossRefGoogle Scholar
  5. 5.
    Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP (2010) Endocr Relat Cancer 17:R53CrossRefGoogle Scholar
  6. 6.
    Fani M, André JP, Maecke HR (2008) Contrast Media Mol Imaging 3:67CrossRefGoogle Scholar
  7. 7.
    Rösch F (2013) Appl Radiat Isot 76:24CrossRefGoogle Scholar
  8. 8.
    Mueller D, Klette I, Baum RP (2013) Recent Results Cancer Res 194:77CrossRefGoogle Scholar
  9. 9.
    Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F (2007) J Nucl Med 48:1741CrossRefGoogle Scholar
  10. 10.
    Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D, Uprimny C, Kovacs P, Bale R, Virgolini IJ (2009) J Nucl Med 50:1427CrossRefGoogle Scholar
  11. 11.
    Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ (2013) Eur J Nucl Med Mol Imaging 40:364CrossRefGoogle Scholar
  12. 12.
    Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H (2007) Eur J Nucl Med Mol Imaging 34:982CrossRefGoogle Scholar
  13. 13.
    Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H (2001) Eur J Nucl Med 28:1751CrossRefGoogle Scholar
  14. 14.
    Chakravarty R, Shukla R, Ram R, Venkatesh M, Dash A, Tyagi AK (2010) ACS Appl Mater Interfaces 2:2069CrossRefGoogle Scholar
  15. 15.
    Chakravarty R, Chakraborty S, Ram R, Dash A, Pillai MRA (2013) Cancer Biother Radiopharm 28:631CrossRefGoogle Scholar
  16. 16.
    Chakraborty S, Chakravarty R, Sarma HD, Dash A, Pillai MRA (2013) Cancer Biother Radiopharm 28:77CrossRefGoogle Scholar
  17. 17.
    Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, von Guggenberg E, Bale R, Virgolini IJ (2007) J Nucl Med 48:508CrossRefGoogle Scholar
  18. 18.
    Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE (2010) Ann Surg 252:850CrossRefGoogle Scholar
  19. 19.
    Ruf J, Heuck F, Schiefer J, Denecke T, Elgeti F, Pascher A, Pavel M, Stelter L, Kropf S, Wiedenmann B, Amthauer H (2010) Neuroendocrinology 91:101CrossRefGoogle Scholar
  20. 20.
    Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C (2013) Cancer Imaging 13:63CrossRefGoogle Scholar
  21. 21.
    Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K (2013) Invest Radiol 48:263CrossRefGoogle Scholar
  22. 22.
    Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C (2013) Recent Results Cancer Res 194:353CrossRefGoogle Scholar
  23. 23.
    Maecke HR, Andrè JP (2007) In: Schubiger PA, Lehmann L, Friebe M (eds) PET chemistry—the driving force in molecular imaging series. Proceedings of the ernst schering foundation symposium, Springer, Berlin, p 215Google Scholar
  24. 24.
    Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Mol Imaging Biol 16:550CrossRefGoogle Scholar
  25. 25.
    Mukherjee A, Korde A, Sarma HD, Samuel G (2014). doi: 10.1007/s10967-014-3308-6

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2014

Authors and Affiliations

  • Archana Mukherjee
    • 1
  • Usha Pandey
    • 1
  • Rubel Chakravarty
    • 1
  • Haladhar Dev Sarma
    • 2
  • Ashutosh Dash
    • 1
  1. 1.Isotope Production & Applications DivisionBhabha Atomic Research CentreMumbaiIndia
  2. 2.Radiation Biology and Health Sciences DivisionBhabha Atomic Research CentreMumbaiIndia

Personalised recommendations